Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Adjusting your budget monthly helps you stay aligned with your financial goals. Explore the benefits of this practice for better control.
23,559 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
As earnings season winds down, March can be a smart time to add leading tech stocks to your portfolio. Explore three ...
Big tech pullbacks can create compelling opportunities. This guide examines whether amazon alphabet among best stocks...
As the Nasdaq pauses, history suggests a potential rebound. This guide dives into two high-growth stocks poised to ri...
Geopolitics can tilt energy markets in a heartbeat. If the Strait Of Hormuz reopens, one ETF could lead the charge hi...
As April 10 approaches, investors debate whether Lilly stock is a buy. This guide breaks down catalysts, valuation, a...
When a company's CEO sells 31,000 shares worth roughly $1.41 million, it sparks questions for investors. This guide e...
Greg Abel, Warren Buffett's successor, signals a bold shift by entering Macy's. This piece breaks down the strategy, ...
In July, investors are weighing recession risks against reliable income. This guide highlights three dividend staples...
Among a long list of there ultra-high-yield dividend stocks, two stand out for safety and consistent income. Learn wh...
A growing glut inventory way—how should savvy investors respond when supply rises and loan terms shift? This guide br...
In the latest SOXX snapshot, AMD rises to the top while Nvidia slides to a close second and Micron inches closer. Lea...